Eisai Inc - Company Profile
Powered by
All the data and insights you need on Eisai Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Eisai Inc Strategy Report
- Understand Eisai Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Eisai Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
JP7409741B2 | Grant | クロロトキシン薬剤及びその使用 | A61K31/337; A61K38/1767; A61K45/06; A61K47/6415; A61K47/6817; A61K49/0019; A61K49/0026; A61K49/0065; A61P35/00; C07K14/43522; C07K17/14 | January 09, 2024 |
JP2020534276A | Application | クロロトキシン薬剤及びその使用 | A61K31/337; A61K38/1767; A61K45/06; A61K47/6415; A61K47/6817; A61K49/0019; A61K49/0026; A61K49/0065; A61P35/00; C07K14/43522; C07K17/14 | November 26, 2020 |
AU2014284212B2 | Grant | Methods for treatment of ovarian cancer | A61K2039/505; A61K2039/545; A61K39/39558; A61K45/06; A61K49/00; A61K9/0019; A61P15/00; A61P35/00; C07K16/28; C07K16/3092; G01N2333/4725; G01N2800/52; G01N33/57449 | September 12, 2019 |
JP6554152B2 | Grant | 葉酸受容体アルファ発現癌の診断および予後マーカーとしての葉酸受容体アルファ | A61K39/395; A61P11/00; A61P15/00; A61P15/08; A61P35/00; G01N2800/52; G01N2800/56; G01N33/574; G01N33/57423; G01N33/57449; G01N33/57484; G01N33/57488; G01N33/82 | July 31, 2019 |
JP2019515265A | Application | バイオマーカーを使用する漿液性卵巣がんの予後 | G01N2333/4704; G01N2333/475; G01N2333/5421; G01N2333/575; G01N2333/71; G01N2333/95; G01N2800/52; G01N2800/56; G01N2800/60; G01N33/57449; G01N33/57484; G16B20/00; G16B5/00 | June 06, 2019 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer